Importantly, low ARHGAP24 expression could help clinicians to identify HCC patients at high risk of recurrence, such as patients with alpha-fetoprotein < 400 μg/μL and early-stage tumors. The gene discussed is ARHGAP24; the disease is hepatocellular carcinoma.